Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07152860Not yet recruiting
Randomised, open-label trial in chronic atrophic gastritis (CAG) (2 arms). Primary endpoint: Total pathological response rate at 24 weeks. Planned start Dec 2025; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07152860.